Site icon OncologyTube

ASH 2015: How Clinical Trials Accelerate Myeloma Treatment Approvals

Are clinical trials still valid as a means for treatment? On location at the 2015 American Society of Hematology (ASH), Medical Correspondent, Carol Preston, speaks with myeloma expert Dr. Sagar Lonial, Chief Medical Officer at Winship Cancer Institute of Emory University, about the rapidly changing therapies for multiple myeloma patients. Listen as Dr. Lonial makes a strong statement for clinical trials as the catalyst for a cure.

Get email alerts | http://www.patientpower.info/alerts

Subscribe on YouTube | http://www.youtube.com/patientpower
Like on Facebook | http://www.fb.com/patientpower.info
Follow on Twitter | http://www.twitter.com/patientpower
Follow on Google+ | http://www.google.com/+patientpowerinfo

Advertisement
Exit mobile version